Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    4638966 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Treatment and Natural History Study of Lymphomatoid Granulomatosis
Conditions: Lymphomatoid Granulomatosis;   Granulomatosis, Lymphomatoid;   Non-Hodgkins Lymphoma;   Lymphoproliferative Disorder
Interventions: Biological: Interferon;   Drug: Rituxan and EPOCH

Indicates status has not been verified in more than two years